Core Insights - Telix Pharmaceuticals Limited will participate in the UBS Global Healthcare Conference and the Jefferies Global Healthcare Conference, showcasing its commitment to engaging with investors and stakeholders in the healthcare sector [1][2]. Company Overview - Telix is a biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic radiopharmaceuticals, addressing significant unmet medical needs in oncology and rare diseases [2]. - The company is headquartered in Melbourne, Australia, with operations in the United States, United Kingdom, Brazil, Canada, Europe (Belgium and Switzerland), and Japan [2]. Upcoming Events - Kevin Richardson, CEO of Precision Medicine, will participate in a fireside chat with UBS on November 10, 2025, at 12:30 PM EST [1]. - Richard Valeix, CEO of Therapeutics, will engage in a fireside chat with Jefferies on November 18, 2025, at 10 AM GMT [2]. - Both sessions will be webcast live and accessible through Telix's Investor Relations website [2].
Telix to Participate in UBS and Jefferies Global Healthcare Conferences